EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Gut dysbiosis aggravates cognitive deficits, amyloid pathology and lipid metabolism dysregulation in a transgenic mouse model of Alzheimer's disease

Chang Qu, Qing-Qing Xu, Wen Yang, Mei Zhong, Qiuju Yuan, Yan-Fang Xian, Zhi-Xiu Lin

Journal of Pharmaceutical Analysis · 2023-12 · 13 (12) · 1526-1547

DOI: 10.1016/j.jpha.2023.07.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical Analysis, 2023-12. Verfasst von Chang Qu und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chinese University of Hong Kong, National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer's diseaseGut dysbiosisNeuropathologyTgCRND8 mice

Autor:innen und Institutionen

  • School of Chinese Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
  • College of Forestry and Landscape Architecture, South China Agricultural University, Guangzhou, 510640, China.
  • Centre for Regenerative Medicine and Health, Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences, Hong Kong Science Park, Shatin, N.T., Hong Kong, China.
  • Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong, Hong Kong, China.

Förderung

  • Chinese University of Hong Kong
  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province

Zitieren

APA

Qu, C., Xu, Q. Q., Yang, W., Zhong, M., Yuan, Q., Xian, Y. F., & Lin, Z. X. (2023). Gut dysbiosis aggravates cognitive deficits, amyloid pathology and lipid metabolism dysregulation in a transgenic mouse model of Alzheimer's disease. Journal of Pharmaceutical Analysis, 13(12), 1526-1547. https://doi.org/10.1016/j.jpha.2023.07.014

Vancouver

Qu C, Xu QQ, Yang W, Zhong M, Yuan Q, Xian YF, et al. Gut dysbiosis aggravates cognitive deficits, amyloid pathology and lipid metabolism dysregulation in a transgenic mouse model of Alzheimer's disease. Journal of Pharmaceutical Analysis. 2023;13(12):1526-1547. doi:10.1016/j.jpha.2023.07.014

BibTeX
@article{Qu2023,
  author = {Qu, Chang and Xu, Qing-Qing and Yang, Wen and Zhong, Mei and Yuan, Qiuju and Xian, Yan-Fang and Lin, Zhi-Xiu},
  title = {Gut dysbiosis aggravates cognitive deficits, amyloid pathology and lipid metabolism dysregulation in a transgenic mouse model of Alzheimer's disease},
  journal = {Journal of Pharmaceutical Analysis},
  year = {2023},
  volume = {13},
  number = {12},
  pages = {1526--1547},
  doi = {10.1016/j.jpha.2023.07.014}
}
Kostenlos starten →